However, although ALT is widely regarded as the most sensitive marker of liver injury in the general population (28, 29), there is currently a lack of evidence regarding which liver enzyme indicator is most suitable for screening NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.